glycoprotein conjugated vaccines (GlycoVaxyn/Janssen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameglycoprotein conjugated vaccines (GlycoVaxyn/Janssen)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycovaxyn Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycovaxyn AgJanssen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A